{"PubmedArticle":[{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"30530974","DateCompleted":{"Year":"2020","Month":"03","Day":"02"},"DateRevised":{"Year":"2020","Month":"03","Day":"09"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1875-8908","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"67","Issue":"1","PubDate":{"Year":"2019"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Next Generation Sequencing Analysis in Early Onset Dementia Patients.","Pagination":{"MedlinePgn":"243-256"},"ELocationID":"10.3233\/JAD-180482","Abstract":{"AbstractText":["Early onset dementias (EOD) are rare neurodegenerative dementias that present before 65 years. Genetic factors have a substantially higher pathogenetic contribution in EOD patients than in late onset dementia.","To identify known and\/or novel rare variants in major candidate genes associated to EOD by high-throughput sequencing. Common-risk variants of apolipoprotein E (APOE) and prion protein (PRNP) genes were also assessed.","We studied 22 EOD patients recruited in Memory Clinics, in the context of studies investigating genetic forms of dementia. Two methodological approaches were applied for the target-Next Generation Sequencing (NGS) analysis of these patients. In addition, we performed progranulin plasma dosage, C9Orf72 hexanucleotide repeat expansion analysis, and APOE genotyping.","We detected three rare known pathogenic mutations in the GRN and PSEN2 genes and eleven unknown-impact mutations in the GRN, VCP, MAPT, FUS, TREM2, and NOTCH3 genes. Six patients were carriers of only common risk variants (APOE and PRNP), and one did not show any risk mutation\/variant. Overall, 69% (n\u200a=\u200a9) of our early onset Alzheimer's disease (EAOD) patients, compared with 34% (n\u200a=\u200a13) of sporadic late onset Alzheimer's disease (LOAD) patients and 27% (n\u200a=\u200a73) of non-affected controls (ADNI, whole genome data), were carriers of at least two rare\/common risk variants in the analyzed candidate genes panel, excluding the full penetrant mutations.","This study suggests that EOD patients without full penetrant mutations are characterized by higher probability to carry polygenic risk alleles that patients with LOAD forms. This finding is in line with recently reported evidence, thus suggesting that the genetic risk factors identified in LOAD might modulate the risk also in EOAD."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Bonvicini","ForeName":"Cristian","Initials":"C","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scassellati","ForeName":"Catia","Initials":"C","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Benussi","ForeName":"Luisa","Initials":"L","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Di Maria","ForeName":"Emilio","Initials":"E","AffiliationInfo":{"Affiliation":"Department of Health Sciences, University of Genova and Division of Medical Genetics, Galliera Hospital, Genova, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Maj","ForeName":"Carlo","Initials":"C","AffiliationInfo":[{"Affiliation":"Genetics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Institute for Genomic Statistics and Bioinformatics, Bonn, Germany."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ciani","ForeName":"Miriam","Initials":"M","AffiliationInfo":[{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Fostinelli","ForeName":"Silvia","Initials":"S","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mega","ForeName":"Anna","Initials":"A","AffiliationInfo":{"Affiliation":"Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Bocchetta","ForeName":"Martina","Initials":"M","AffiliationInfo":[{"Affiliation":"Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Lanzi","ForeName":"Gaetana","Initials":"G","AffiliationInfo":{"Affiliation":"A. Nocivelli' Institute for Molecular Medicine Spedali Civili and University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Giacopuzzi","ForeName":"Edoardo","Initials":"E","AffiliationInfo":[{"Affiliation":"Genetics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ferraboli","ForeName":"Sergio","Initials":"S","AffiliationInfo":{"Affiliation":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pievani","ForeName":"Michela","Initials":"M","AffiliationInfo":{"Affiliation":"Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fedi","ForeName":"Virginia","Initials":"V","AffiliationInfo":{"Affiliation":"Fondazione Case Serena, Pontoglio, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Defanti","ForeName":"Carlo Alberto","Initials":"CA","AffiliationInfo":{"Affiliation":"Fondazione Europea Ricerca Biomedica, Centro di Eccellenza Alzheimer, Ospedale Briolini Gazzaniga, Bergamo, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Giliani","ForeName":"Silvia","Initials":"S","AffiliationInfo":{"Affiliation":"A. Nocivelli' Institute for Molecular Medicine Spedali Civili and University of Brescia, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Alzheimer\u2019s Disease Neuroimaging Initiative"},{"@attributes":{"ValidYN":"Y"},"LastName":"Frisoni","ForeName":"Giovanni Battista","Initials":"GB","AffiliationInfo":[{"Affiliation":"Laboratory Alzheimer's Neuroimaging and Epidemiology, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Laboratory of Neuroimaging of Aging (LANVIE), University Hospitals and University of Geneva, Geneva, Switzerland; Department of Internal Medicine, University Hospitals and University of Geneva, Geneva, Switzerland."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghidoni","ForeName":"Roberta","Initials":"R","AffiliationInfo":{"Affiliation":"Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gennarelli","ForeName":"Massimo","Initials":"M","AffiliationInfo":[{"Affiliation":"Genetics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy."},{"Affiliation":"Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."}]}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"U01 AG024904","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"Agency":"CIHR","Country":"Canada"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, Non-P.H.S."]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 Protein"},{"RegistryNumber":"0","NameOfSubstance":"C9orf72 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"PRNP protein, human"},{"RegistryNumber":"0","NameOfSubstance":"PSEN2 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"Presenilin-2"},{"RegistryNumber":"0","NameOfSubstance":"Prion Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Alleles"},{"DescriptorName":"Apolipoproteins E","QualifierName":"genetics"},{"DescriptorName":"C9orf72 Protein","QualifierName":"genetics"},{"DescriptorName":"Dementia","QualifierName":"genetics"},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Association Studies"},{"DescriptorName":"Genetic Variation"},{"DescriptorName":"High-Throughput Nucleotide Sequencing","QualifierName":"trends"},{"DescriptorName":"Humans"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Presenilin-2","QualifierName":"genetics"},{"DescriptorName":"Prion Proteins","QualifierName":"genetics"},{"DescriptorName":"Retrospective Studies"},{"DescriptorName":"Risk Assessment"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Alzheimer\u2019s disease","Lewy body dementia","common variants","early onset dementia","frontotemporal \ndementia","next generation sequencing","rare mutations"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2018","Month":"12","Day":"12","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2020","Month":"3","Day":"3","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2018","Month":"12","Day":"12","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["30530974","JAD180482","10.3233\/JAD-180482","PMC6398561"]},"ReferenceList":{"Reference":[{"Citation":"N Engl J Med. 2013 Oct 17;369(16):1569-70","ArticleIdList":{"ArticleId":"24143816"}},{"Citation":"J Alzheimers Dis. 2013;33(1):69-76","ArticleIdList":{"ArticleId":"22890101"}},{"Citation":"Neurobiol Aging. 2013 Aug;34(8):2077.e11-8","ArticleIdList":{"ArticleId":"23582655"}},{"Citation":"Nat Methods. 2010 Aug;7(8):575-6","ArticleIdList":{"ArticleId":"20676075"}},{"Citation":"Neurology. 1994 Jul;44(7):1215-20","ArticleIdList":{"ArticleId":"8035918"}},{"Citation":"Neurobiol Dis. 2009 Mar;33(3):379-85","ArticleIdList":{"ArticleId":"19101631"}},{"Citation":"Neuropsychol Rev. 2015 Mar;25(1):113-24","ArticleIdList":{"ArticleId":"25567624"}},{"Citation":"Mol Psychiatry. 2014 Mar;19(3):351-7","ArticleIdList":{"ArticleId":"23419831"}},{"Citation":"Neuron. 2011 Oct 20;72(2):257-68","ArticleIdList":{"ArticleId":"21944779"}},{"Citation":"Am J Hum Genet. 1994 Oct;55(4):714-27","ArticleIdList":{"ArticleId":"7942850"}},{"Citation":"Brain. 2009 Mar;132(Pt 3):583-91","ArticleIdList":{"ArticleId":"19158106"}},{"Citation":"Aging Dis. 2018 Aug 1;9(4):696-705","ArticleIdList":{"ArticleId":"30090657"}},{"Citation":"Curr Protoc Hum Genet. 2003 Nov;Chapter 9:Unit9.14","ArticleIdList":{"ArticleId":"18428347"}},{"Citation":"Brain. 2007 Sep;130(Pt 9):2277-91","ArticleIdList":{"ArticleId":"17681982"}},{"Citation":"Nat Rev Neurosci. 2016 Apr;17(4):201-7","ArticleIdList":{"ArticleId":"26911435"}},{"Citation":"J Alzheimers Dis. 2018;61(2):753-760","ArticleIdList":{"ArticleId":"29226869"}},{"Citation":"Clin Genet. 2008 Jul;74(1):54-60","ArticleIdList":{"ArticleId":"18341608"}},{"Citation":"Neurodegener Dis. 2012;9(3):121-7","ArticleIdList":{"ArticleId":"22123177"}},{"Citation":"Neurobiol Aging. 2018 Jun;66:180.e23-180.e31","ArticleIdList":{"ArticleId":"29525180"}},{"Citation":"Lancet Neurol. 2018 May;17(5):434-444","ArticleIdList":{"ArticleId":"29555425"}},{"Citation":"Neurobiol Aging. 2014 Mar;35(3):726.e11-9","ArticleIdList":{"ArticleId":"24119542"}},{"Citation":"Clin Interv Aging. 2014 Apr 01;9:535-51","ArticleIdList":{"ArticleId":"24729694"}},{"Citation":"Hum Mutat. 2013 Jan;34(1):57-65","ArticleIdList":{"ArticleId":"23033316"}},{"Citation":"Curr Alzheimer Res. 2015;12(8):802-12","ArticleIdList":{"ArticleId":"26159191"}},{"Citation":"PLoS Comput Biol. 2010 Dec 02;6(12):e1001025","ArticleIdList":{"ArticleId":"21152010"}},{"Citation":"Neurology. 2008 Oct 14;71(16):1235-9","ArticleIdList":{"ArticleId":"18768919"}},{"Citation":"Genome Res. 2009 Sep;19(9):1553-61","ArticleIdList":{"ArticleId":"19602639"}},{"Citation":"JAMA Neurol. 2014 Apr;71(4):449-53","ArticleIdList":{"ArticleId":"24535663"}},{"Citation":"Am J Hum Genet. 2008 Nov;83(5):623-32","ArticleIdList":{"ArticleId":"18976728"}},{"Citation":"Neurobiol Aging. 2014 Oct;35(10):2419.e23-2419.e25","ArticleIdList":{"ArticleId":"24910390"}},{"Citation":"J Neurol Sci. 2013 Mar 15;326(1-2):89-95","ArticleIdList":{"ArticleId":"23399523"}},{"Citation":"Iran J Public Health. 2015 Jul;44(7):892-901","ArticleIdList":{"ArticleId":"26576367"}},{"Citation":"OMICS. 2014 Feb;18(2):142-54","ArticleIdList":{"ArticleId":"24286505"}},{"Citation":"Int J Geriatr Psychiatry. 2010 Nov;25(11):1091-100","ArticleIdList":{"ArticleId":"20957692"}},{"Citation":"Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):308-9","ArticleIdList":{"ArticleId":"20798611"}},{"Citation":"Int J Psychiatry Med. 2006;36(4):401-12","ArticleIdList":{"ArticleId":"17407994"}},{"Citation":"Arch Neurol. 2010 Aug;67(8):970-5","ArticleIdList":{"ArticleId":"20697047"}},{"Citation":"Curr Alzheimer Res. 2004 Aug;1(3):215-8","ArticleIdList":{"ArticleId":"15975068"}},{"Citation":"Front Med (Lausanne). 2018 Apr 24;5:108","ArticleIdList":{"ArticleId":"29740579"}},{"Citation":"Neuron. 2011 Oct 20;72(2):245-56","ArticleIdList":{"ArticleId":"21944778"}},{"Citation":"Clin Neuropathol. 2007 Sep-Oct;26(5):232-40","ArticleIdList":{"ArticleId":"17907600"}},{"Citation":"Neurobiol Aging. 2014 Jan;35(1):261-5","ArticleIdList":{"ArticleId":"23998997"}},{"Citation":"Hum Mol Genet. 2014 Dec 1;23(23):6139-46","ArticleIdList":{"ArticleId":"24973356"}},{"Citation":"Neurol Sci. 2009 Jun;30(3):269-71","ArticleIdList":{"ArticleId":"19259619"}},{"Citation":"Hum Mol Genet. 1997;6(10):1699-705","ArticleIdList":{"ArticleId":"9300662"}},{"Citation":"Clin Chim Acta. 2016 Dec 1;463:88-95","ArticleIdList":{"ArticleId":"27769848"}},{"Citation":"N Engl J Med. 2013 Jan 10;368(2):107-16","ArticleIdList":{"ArticleId":"23150908"}},{"Citation":"Lancet. 2014 Mar 1;383(9919):828-40","ArticleIdList":{"ArticleId":"23927914"}},{"Citation":"Alzheimers Dement. 2018 Feb;14(2):205-214","ArticleIdList":{"ArticleId":"28943286"}},{"Citation":"Prog Neurobiol. 2013 Nov;110:2-28","ArticleIdList":{"ArticleId":"24036231"}},{"Citation":"Genome Biol. 2017 Apr 27;18(1):77","ArticleIdList":{"ArticleId":"28449691"}},{"Citation":"JAMA Neurol. 2015 Aug;72(8):920-7","ArticleIdList":{"ArticleId":"26076170"}},{"Citation":"Development. 2017 May 15;144(10):1743-1763","ArticleIdList":{"ArticleId":"28512196"}},{"Citation":"Mol Neurodegener. 2013 Jun 21;8:19","ArticleIdList":{"ArticleId":"23800361"}},{"Citation":"J Neuropathol Exp Neurol. 2004 Mar;63(3):199-209","ArticleIdList":{"ArticleId":"15055444"}},{"Citation":"Alzheimers Dement. 2016 Jun;12(6):733-48","ArticleIdList":{"ArticleId":"27016693"}},{"Citation":"N Engl J Med. 2013 Jan 10;368(2):117-27","ArticleIdList":{"ArticleId":"23150934"}},{"Citation":"Nat Genet. 2014 Mar;46(3):310-5","ArticleIdList":{"ArticleId":"24487276"}},{"Citation":"JAMA Neurol. 2013 Nov;70(11):1411-7","ArticleIdList":{"ArticleId":"24081456"}},{"Citation":"FASEB J. 2016 Feb;30(2):503-6","ArticleIdList":{"ArticleId":"26527064"}},{"Citation":"Brain. 2007 Feb;130(Pt 2):381-93","ArticleIdList":{"ArticleId":"16984901"}},{"Citation":"Neurology. 2006 Aug 22;67(4):644-51","ArticleIdList":{"ArticleId":"16790606"}},{"Citation":"Neurobiol Aging. 2015 Aug;36(8):2443.e21-6","ArticleIdList":{"ArticleId":"26058841"}},{"Citation":"J Biol Chem. 2015 Oct 23;290(43):26033-42","ArticleIdList":{"ArticleId":"26374897"}},{"Citation":"Neurobiol Aging. 2013 Jun;34(6):1711.e15-7","ArticleIdList":{"ArticleId":"23391427"}},{"Citation":"J Alzheimers Dis. 2016 Apr 19;52(4):1157-76","ArticleIdList":{"ArticleId":"27104909"}},{"Citation":"JAMA Neurol. 2013 Jan;70(1):78-84","ArticleIdList":{"ArticleId":"23318515"}},{"Citation":"J Alzheimers Dis. 2014;38(4):799-808","ArticleIdList":{"ArticleId":"24064469"}},{"Citation":"Neurology. 2000 May 23;54(10):2006-8","ArticleIdList":{"ArticleId":"10822446"}},{"Citation":"Neurobiol Aging. 2016 Apr;40:192.e7-192.e11","ArticleIdList":{"ArticleId":"26925509"}},{"Citation":"J Biol Chem. 2015 Oct 23;290(43):26043-50","ArticleIdList":{"ArticleId":"26374899"}},{"Citation":"Neurology. 2002 Nov 26;59(10):1619-21","ArticleIdList":{"ArticleId":"12451207"}},{"Citation":"Mol Neurodegener. 2015 Apr 10;10:19","ArticleIdList":{"ArticleId":"25886450"}},{"Citation":"Eur J Neurol. 2012 Mar;19(3):501-9","ArticleIdList":{"ArticleId":"22040362"}},{"Citation":"Ann Neurol. 2003 Mar;53(3):409-12","ArticleIdList":{"ArticleId":"12601712"}},{"Citation":"Bioinformatics. 2010 Mar 15;26(6):841-2","ArticleIdList":{"ArticleId":"20110278"}},{"Citation":"Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20","ArticleIdList":{"ArticleId":"23315928"}},{"Citation":"Ann Neurol. 2009 May;65(5):603-9","ArticleIdList":{"ArticleId":"19288468"}},{"Citation":"Parkinsonism Relat Disord. 2015 Mar;21(3):306-9","ArticleIdList":{"ArticleId":"25585992"}},{"Citation":"Genome Res. 2010 Jan;20(1):110-21","ArticleIdList":{"ArticleId":"19858363"}},{"Citation":"Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13615-20","ArticleIdList":{"ArticleId":"26483451"}},{"Citation":"Nat Protoc. 2009;4(7):1073-81","ArticleIdList":{"ArticleId":"19561590"}},{"Citation":"Genet Med. 2004 Jul-Aug;6(4):197-203","ArticleIdList":{"ArticleId":"15266207"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25072545","DateCompleted":{"Year":"2014","Month":"10","Day":"30"},"DateRevised":{"Year":"2015","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0034-1193","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"105","Issue":"7-8","PubDate":{"MedlineDate":"2014 Jul-Aug"}},"Title":"Recenti progressi in medicina","ISOAbbreviation":"Recenti Prog Med"},"ArticleTitle":"[Diagnosing Alzheimer's disease: from research to clinical practice and ethics].","Pagination":{"MedlinePgn":"295-9"},"ELocationID":"10.1701\/1574.17116","Abstract":{"AbstractText":"In 2011, the so-called Dubois criteria introduced the use of biomarkers in research (in particular, brain amyloid positron emission tomography imaging and the cerebrospinal fluid levels of tau\/fosfo-tau and beta-amyloid 1-42) for the early or preclinical diagnosis of Alzheimer's disease. Even so, we are looking at an increased use of these markers in clinical practice. In the 1960s, Alzheimer's disease was considered a rare form of presenile dementia, but gradually it has been recognized as the prevalent form of old-age dementia. As a consequence, what was once regarded as an inevitable outcome of old age is now recognized as a true disease. Several factors contributed to this paradigm shift, in particular a longer lifespan, new techniques of in vivo study of the central nervous system, and the pressure exerted by the pharmaceutical industry and patient groups. The current lack of disease-modifying therapies and the high incidence of mild cognitive impairment, which is a risk factor for dementia, raise a series of clinical ethical problems ranging from how diagnosis is communicated to how resources are used. This article offers a conceptual scheme through which these issues can be addressed. "},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Tarquini","ForeName":"Daniela","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Pucci","ForeName":"Eugenio","Initials":"E"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gasparini","ForeName":"Maddalena","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zullo","ForeName":"Silvia","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tiraboschi","ForeName":"Pietro","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Bonito","ForeName":"Virginio","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Defanti","ForeName":"Carlo Alberto","Initials":"CA"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Gruppo di Studio in Bioetica e Cure Palliative della Societ\u00e0 Italiana di Neurologia"}]},"Language":"ita","PublicationTypeList":{"PublicationType":["English Abstract","Journal Article"]},"VernacularTitle":"Malattia di Alzheimer: la diagnosi tra ricerca, prassi clinica ed etica."},"MedlineJournalInfo":{"Country":"Italy","MedlineTA":"Recenti Prog Med","NlmUniqueID":"0401271","ISSNLinking":"0034-1193"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Biomarkers"},{"RegistryNumber":"0","NameOfSubstance":"Membrane Proteins"},{"RegistryNumber":"0","NameOfSubstance":"tau 40 protein, human"},{"RegistryNumber":"0","NameOfSubstance":"tau Proteins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","diagnosis"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Biomarkers","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Biomedical Research","QualifierName":"ethics"},{"DescriptorName":"Diagnosis, Differential"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Early Diagnosis"},{"DescriptorName":"Humans"},{"DescriptorName":"Membrane Proteins","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"Positron-Emission Tomography"},{"DescriptorName":"Predictive Value of Tests"},{"DescriptorName":"Sensitivity and Specificity"},{"DescriptorName":"tau Proteins","QualifierName":"cerebrospinal fluid"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"7","Day":"30","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"7","Day":"30","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"10","Day":"31","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25072545","10.1701\/1574.17116"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12700907","DateCompleted":{"Year":"2003","Month":"06","Day":"09"},"DateRevised":{"Year":"2009","Month":"11","Day":"19"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0340-5354","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"250","Issue":"4","PubDate":{"Year":"2003","Month":"Apr"}},"Title":"Journal of neurology","ISOAbbreviation":"J Neurol"},"ArticleTitle":"Cause and course in a series of patients with sporadic chorea.","Pagination":{"MedlinePgn":"429-35"},"Abstract":{"AbstractText":["To identify correlations between clinical and neuroimaging features in sporadic chorea and to explicate the evolution of choreas of differing aetiologies.","We analysed the clinical and neuroimaging data of 51 consecutive cases (17 males, 34 females; age 16-95 years) of sporadic chorea admitted to the neurology departments of two general hospitals from January 1994 to December 1999, and two neurological institutes from January 1997. Six months later the patients were reassessed clinically and those still with chorea (20 cases) were asked to undergo the genetic tests for Huntington's disease and dentatorubropallidoluysian atrophy.","There were 9 cases of focal dyskinesias, 18 of hemichorea, and 24 of generalised chorea; onset was acute in 17, subacute in 27, and insidious in seven. Analysis permitted classification as follows: vascular-related (21 cases); vasculitis (1 case); hypoxia (2 cases); drug-induced (7 cases); AIDS-related (5 cases), borreliosis (1 case); Sydenham's chorea (1 case); hyperglycaemia (2 cases); hyponatraemia (2 cases); Huntington's disease (HD) (5 cases) and acanthocytosis (1 case). In 3 patients neither etiological factors nor neuroradiological alterations were found.","Although a convincing concordance between choreic signs and neuroradiological findings was possible in 4 patients only, it was possible to assign an aetiology in most cases with vascular related causes the most frequent and metabolic factors often participating. Huntington's disease is not unusual as a cause of sporadic choreas. HIV infection is an emerging cause of chorea and AIDS-related disease should be considered in young patients presenting without a family history of movement disorders. We emphasize the importance of follow-up to identify persistent chorea for which genetic testing is mandatory."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Piccolo","ForeName":"Immacolata","Initials":"I","AffiliationInfo":{"Affiliation":"Unit\u00e0 Spinale, Niguarda C\u00e0 Granda Hospital, Piazza Ospedale Maggiore 3, 20162 Milano, Italy."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Defanti","ForeName":"Carlo Alberto","Initials":"CA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Soliveri","ForeName":"Paola","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Volont\u00e8","ForeName":"Maria Antonietta","Initials":"MA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Cislaghi","ForeName":"Giuliana","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Girotti","ForeName":"Floriano","Initials":"F"}]},"Language":"eng","PublicationTypeList":{"PublicationType":"Journal Article"}},"MedlineJournalInfo":{"Country":"Germany","MedlineTA":"J Neurol","NlmUniqueID":"0423161","ISSNLinking":"0340-5354"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adolescent"},{"DescriptorName":"Adult"},{"DescriptorName":"Age of Onset"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Cerebrovascular Disorders","QualifierName":"complications"},{"DescriptorName":"Chorea","QualifierName":["etiology","genetics","pathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Genetic Testing"},{"DescriptorName":"HIV Infections","QualifierName":"complications"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":["etiology","genetics","pathology"]},{"DescriptorName":"Male"},{"DescriptorName":"Metabolic Diseases","QualifierName":"complications"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Retrospective Studies"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2003","Month":"4","Day":"18","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2003","Month":"6","Day":"10","Hour":"5","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2003","Month":"4","Day":"18","Hour":"5","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12700907","10.1007\/s00415-003-1010-7"]}}}]}